Armstrong Advisory Group, Inc Amneal Pharmaceuticals, Inc. Transaction History
Armstrong Advisory Group, Inc
- $1.31 Billion
- Q3 2025
A detailed history of Armstrong Advisory Group, Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 150 shares of AMRX stock, worth $1,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$1,467
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
249Shares Held
145MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$172 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$121 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$115 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$110 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$55 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.48B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...